Suchergebnisse - "Mondejar-Parreño, Gema"

PubPharm (32)

1

Elucidating effects of the environmental pollutant benzo[a]pyrene [BaP] on cardiac arrhythmogenicity

enthalten in: Journal of molecular and cellular cardiology | 2024

von Yang, J. | Mondéjar-Parreño, G. | Jahng, J. | +7

2

Disparities in cardio-oncology : Implication of angiogenesis, inflammation, and chemotherapy

enthalten in: Life sciences | 2023

von Vera, C. | López, A. | Ewaneewane, A. | +5

3

Unraveling the Role of K2P Channels in Atrial Fibrillation

enthalten in: Frontiers in bioscience (Scholar edition) | 2022

von Mondéjar-Parreño, G.

4

Antiproliferative miR-212-5p : Promising RNA therapy for pulmonary hypertension

enthalten in: Molecular therapy. Nucleic acids | 2022

von Perez-Vizcaino, F. | Mondejar-Parreño, G.

5

Cardiac and Pulmonary Vascular Dysfunction in Vitamin D-Deficient Bmpr2-Mutant Rats

enthalten in: American journal of respiratory cell and molecular biology | 2022

von Olivencia, M. | Esquivel-Ruiz, S. | Callejo, M. | +8

6

Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients

enthalten in: Stem cell research | 2022

von Caudal, A. | Mondejar-Parreño, G. | Vera, C. | +4

7

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

enthalten in: Journal of visualized experiments : JoVE | 2022

von Zhao, S. | Mondéjar-Parreño, G. | Li, D. | +2

8

Potassium (K+) channels in the pulmonary vasculature : Implications in pulmonary hypertension Physiological, pathophysiological and pharmacological regulation

enthalten in: Pharmacology & therapeutics | 2021

von Mondéjar-Parreño, G. | Cogolludo, A. | Perez-Vizcaino, F.

9

Transcriptomic profile of cationic channels in human pulmonary arterial hypertension

enthalten in: Scientific reports | 2021

von Perez-Vizcaino, F. | Cogolludo, A. | Mondejar-Parreño, G.

10

Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome

enthalten in: Stem cell research | 2021

von Mondéjar-Parreño, G. | Jahng, J. | Belbachir, N. | +5